Myriad Genetics Inc (NASDAQ:MYGN)

20.93
Delayed Data
As of Dec 02
 +0.59 / +2.90%
Today’s Change
15.38
Today|||52-Week Range
28.45
-24.17%
Year-to-Date

Today’s Trading

Previous close20.34
Today’s open19.81
Day’s range19.81 - 21.00
Volume20,300
Average volume (3 months)542,988
Market cap$1.7B
Data as of 3:59pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)+87.01%
Earnings growth (this year)-1,822.22%
Earnings growth (next 5 years)-10.28%
Revenue growth (last year)+8.14%
P/E ratioNM
Price/Sales3.12
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.71+1.94%
----
VIVOMeridian Bioscience ...-0.01-0.03%
VCYTVeracyte Inc+0.31+1.08%
Data as of 4:00pm ET, 12/02/2022

Financials

Next reporting dateFebruary 23, 2023
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$690.6M
Annual profit (last year)-$27.2M
Net profit margin-3.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts